Notice of Annual General Meeting of Shareholders
May 12 2015 - 02:40AM
The Board of Directors of Active Biotech AB (publ) has issued a
notice to the Annual General Meeting, which is to take place at 5
p.m. on Thursday, June 11, 2015, at 5 pm at Elite Hotel Ideon,
Scheelevägen 27 in Lund, Sweden.
Please see the attached notification, which is being announced
within short in Svenska Dagbladet and Post- och Inrikes
Tidningar.
Lund, May 12, 2015ACTIVE BIOTECH AB (PUBL)THE BOARD OF
DIRECTORS
Active Biotech AB (publ) (Nasdaq
Stockholm: ACTI) is a biotechnology company with focus on
neurodegenerative/inflammatory diseases and cancer. Laquinimod, an
orally administered small molecule with unique immunomodulatory
properties, is in pivotal phase III development for the treatment
of relapsing remitting multiple sclerosis. Also, laquinimod is in
phase II development for the treatment of primary progressive
multiple sclerosis and Huntington's disease. The project portfolio
includes a preclinical project, ISI, with the objective to produce
new, patentable chemical compounds for treatment of diseases within
the company's focus areas. Please visit www.activebiotech.com for
more information.
Active Biotech AB (Corp. Reg. No.
556223-9227)Box 724, SE-220 07 LundTel: +46 46 19 20 00 Fax: +46 46
19 11 00
Active Biotech is required under the Financial Instruments
Trading Act to make the information in this press release public.
The information was submitted for publication at 08:30 a.m. CET on
May 12, 2015.
Notice of Annual General Meeting of Shareholders
http://hugin.info/1002/R/1920502/688008.pdf
HUG#1920502
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Actividentity Corp (MM) (NASDAQ:ACTI)
Historical Stock Chart
From Mar 2023 to Mar 2024